Advisory Board on Radiation and Worker Health, National Institute for Occupational Safety and Health, 41986-41987 [2020-15028]
Download as PDF
<![CDATA[
41986
Federal Register / Vol. 85, No. 134 / Monday, July 13, 2020 / Notices
FOR FURTHER INFORMATION CONTACT:
Stephanie Thomas, ACIP Committee
Management Specialist, Centers for
Disease Control and Prevention,
National Center for Immunization and
Respiratory Diseases, 1600 Clifton Road,
NE, MS–H24–8, Atlanta, GA 30329–
4027; Telephone: 404–639–8367; Email:
ACIP@cdc.gov.
SUPPLEMENTARY INFORMATION:
Purpose: The committee is charged
with advising the Director, CDC, on the
use of immunizing agents. In addition,
under 42 U.S.C. 1396s, the committee is
mandated to establish and periodically
review and, as appropriate, revise the
list of vaccines for administration to
vaccine-eligible children through the
Vaccines for Children (VFC) program,
along with schedules regarding dosing
interval, dosage, and contraindications
to administration of vaccines. Further,
under provisions of the Affordable Care
Act, section 2713 of the Public Health
Service Act, immunization
recommendations of the ACIP that have
been approved by the Director of the
Centers for Disease Control and
Prevention and appear on CDC
immunization schedules must be
covered by applicable health plans.
Matters To Be Considered: The agenda
will include discussions on COVID–19
vaccines. No recommendation votes are
scheduled. Agenda items are subject to
change as priorities dictate. For more
information on the meeting agenda visit
https://www.cdc.gov/vaccines/acip/
meetings/meetings-info.html.
Meeting Information: The meeting
will be webcast live via the World Wide
Web; for more information on ACIP
please visit the ACIP website: https://
www.cdc.gov/vaccines/acip/.
jbell on DSKJLSW7X2PROD with NOTICES
Public Participation
Interested persons or organizations
are invited to participate by submitting
written views, recommendations, and
data. Comments received are part of the
public record and are subject to public
disclosure. Do not include any
information in your comment or
supporting materials that you consider
confidential or inappropriate for public
disclosure. If you include your name,
contact information, or other
information that identifies you in the
body of your comments, that
information will be on public display.
CDC will review all submissions and
may choose to redact, or withhold,
submissions containing private or
proprietary information such as Social
Security numbers, medical information,
inappropriate language, or duplicate/
near duplicate examples of a mass-mail
campaign. CDC will carefully consider
VerDate Sep<11>2014
20:25 Jul 10, 2020
Jkt 250001
all comments submitted into the docket.
CDC does not accept comment by email.
Oral Public Comment: This meeting
will include time for members of the
public to make an oral comment. Oral
public comment will occur before any
scheduled votes including all votes
relevant to the ACIP’s Affordable Care
Act and Vaccines for Children Program
roles. Priority will be given to
individuals who submit a request to
make an oral public comment before the
meeting according to the procedures
below.
Procedure for Oral Public Comment:
All persons interested in making an oral
public comment at the July ACIP
meeting must submit a request at https://
www.cdc.gov/vaccines/acip/meetings/
no later than 11:59 p.m., EDT, July 22,
2020 according to the instructions
provided.
If the number of persons requesting to
speak is greater than can be reasonably
accommodated during the scheduled
time, CDC will conduct a lottery to
determine the speakers for the
scheduled public comment session.
CDC staff will notify individuals
regarding their request to speak by email
by July 23, 2020. To accommodate the
significant interest in participation in
the oral public comment session of
ACIP meetings, each speaker will be
limited to 3 minutes, and each speaker
may only speak once per meeting.
Written Public Comment: Written
comments must be received on or before
July 30, 2020. Written public comments
submitted by 72 hours prior to the ACIP
meeting will be provided to ACIP
members before the meeting.
This notice is being published less
than 15 days prior to the meeting due
to the public health emergency declared
on January 27, 2020. There is a critical
need for this committee to discuss
urgent matters related to discussions on
COVID–19 vaccines and be actively
engaged in the national response efforts
as dictated by circumstances and events.
In the interest of promoting openness
and transparency, we are publishing a
late notice in the Federal Register to
inform the public.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
PO 00000
Frm 00049
Fmt 4703
Sfmt 4703
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2020–15178 Filed 7–9–20; 3:00 pm]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[Docket No. CDC–2020–0077]; [Docket No.
NIOSH 338]
Advisory Board on Radiation and
Worker Health, National Institute for
Occupational Safety and Health
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting and request
for comment.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
CDC, announces the following meeting
of the Advisory Board on Radiation and
Worker Health (ABRWH). This meeting
is open to the public, limited only by
the space available. The audio
conference line has 150 ports for callers.
The public is welcome to submit written
comments in advance of the meeting, to
the contact person below. Written
comments received in advance of the
meeting will be included in the official
record of the meeting. The public is also
welcome to listen to the meeting by
joining the teleconference (information
below).
SUMMARY:
The meeting will be held on
August 26, 2020 from 1:15 p.m. to 6:15
p.m., EDT and August 27, 2020 from
1:15 p.m. to 6:30 p.m., EDT. An oral
public comment session will be held on
August 26, 2020 at 5:15 p.m. and
conclude at 6:15 p.m., or following the
final call for public comment,
whichever comes first.
Written comments must be received
on or before August 21, 2020.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2020–
0077, Docket No. NIOSH–338 by either
of the following methods listed below.
CDC does not accept comment by email.
• Federal eRulemaking Portal: https://
www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: Docket No. CDC–2020–0077,
Docket number NIOSH–338 c/o Sherri
Diana, NIOSH Docket Office, National
Institute for Occupational Safety and
DATES:
E:\FR\FM\13JYN1.SGM
13JYN1
jbell on DSKJLSW7X2PROD with NOTICES
Federal Register / Vol. 85, No. 134 / Monday, July 13, 2020 / Notices
Health, 1090 Tusculum Avenue, MS C–
34, Cincinnati, Ohio 45226.
Instructions: All submissions received
must include the Agency name and
Docket Number. All relevant comments
received in conformance with the
https://www.regulations.gov suitability
policy will be posted without change to
https://www.regulations.gov, including
any personal information provided. For
access to the docket to read background
documents or comments received, go to
https://www.regulations.gov.
FOR FURTHER INFORMATION CONTACT:
Rashaun Roberts, Ph.D., Designated
Federal Officer, NIOSH, CDC, 1090
Tusculum Avenue, Mailstop C–24,
Cincinnati, Ohio 45226, Telephone
(513) 533–6800, Toll Free 1(800)CDC–
INFO, Email ocas@cdc.gov.
SUPPLEMENTARY INFORMATION:
Background: The Advisory Board was
established under the
Energy Employees Occupational
Illness Compensation Program Act of
2000 to advise the President on a variety
of policy and technical functions
required to implement and effectively
manage the new compensation program.
Key functions of the Advisory Board
include providing advice on the
development of probability of causation
guidelines which have been
promulgated by the Department of
Health and Human Services (HHS) as a
final rule, advice on methods of dose
reconstruction which have also been
promulgated by HHS as a final rule,
advice on the scientific validity and
quality of dose estimation and
reconstruction efforts being performed
for purposes of the compensation
program, and advice on petitions to add
classes of workers to the Special
Exposure Cohort (SEC). In December
2000, the President delegated
responsibility for funding, staffing, and
operating the Advisory Board to HHS,
which subsequently delegated this
authority to the CDC. NIOSH
implements this responsibility for CDC.
The Advisory Board’s charter was
issued on August 3, 2001, renewed at
appropriate intervals, rechartered on
March 22, 2020, and will terminate on
March 22, 2022.
Purpose: This Advisory Board is
charged with (a) providing advice to the
Secretary, HHS, on the development of
guidelines under Executive Order
13179; (b) providing advice to the
Secretary, HHS, on the scientific
validity and quality of dose
reconstruction efforts performed for this
program; and (c) upon request by the
Secretary, HHS, advising the Secretary
on whether there is a class of employees
at any Department of Energy facility
VerDate Sep<11>2014
20:25 Jul 10, 2020
Jkt 250001
who were exposed to radiation but for
whom it is not feasible to estimate their
radiation dose, and on whether there is
reasonable likelihood that such
radiation doses may have endangered
the health of members of this class.
Matters to Be Considered: The agenda
will include discussions on the
following: NIOSH Program Update;
Department of Labor Program Update;
Department of Energy Program Update;
SEC Petitions Update; Completed Site
Profile Review for W.R Grace Company
(Erwin, Tennessee); Update on Site
Profile Review for Idaho National
Laboratory Site (Burial Ground and
other Exposure Scenarios), and Hanford
(Richland, Washington); SEC Petition
Reviews for Superior Steel (Carnegie,
Pennsylvania; 1952–2957), and
Reduction Pilot Plant (Huntington, West
Virginia; 1976–1978), and a Board Work
Session. Agenda items are subject to
change as priorities dictate.
Meeting Information: The USA tollfree dial-in number is 1–866–659–0537;
the pass code is 9933701. Web
conference by Skype: meeting
Connection: https://webconf.cdc.gov/
zab6/yzdq02pl?sl=1.
Public Participation
Comments received are part of the
public record and are subject to public
disclosure. Do not include any
information in your comment or
supporting materials that you consider
confidential or inappropriate for public
disclosure. If you include your name,
contact information, or other
information that identifies you in the
body of your comments, that
information will be on public display.
CDC will review all submissions and
may choose to redact, or withhold,
submissions containing private or
proprietary information such as Social
Security numbers, medical information,
inappropriate language, or duplicate/
near duplicate examples of a mass-mail
campaign. CDC will carefully consider
all comments submitted into the docket.
CDC does not accept comment by email.
Oral Public Comment: An oral public
comment session will be held on August
26, 2020 at 5:15 p.m., EDT and conclude
at 6:15 p.m., EDT or following the final
call for public comment, whichever
comes first.
Written Public Comment: Written
comments will also be accepted from
those unable to attend the public
session per the instructions provided in
the address section above. Written
comments received in advance of the
meeting will be included in the official
record of the meeting.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
PO 00000
Frm 00050
Fmt 4703
Sfmt 4703
41987
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2020–15028 Filed 7–10–20; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2018–D–2494]
Select Updates for Peripheral Vascular
Atherectomy Devices—Premarket
Notification Submissions; Draft
Guidance for Industry and Food and
Drug Administration Staff; Availability
Food and Drug Administration,
Health and Human Services (HHS).
ACTION: Notice of availability.
AGENCY:
The Food and Drug
Administration (FDA or Agency) is
announcing the availability of the draft
guidance entitled ‘‘Select Updates for
Peripheral Vascular Atherectomy
Devices—Premarket Notification
(510(k)) Submissions.’’ FDA has
developed this draft guidance to
propose select updates to certain
sections of the existing FDA guidance
document ‘‘Peripheral Vascular
Atherectomy Devices—Premarket
Notification (510(k)) Submissions.’’ This
draft guidance is not final nor is it in
effect at this time.
DATES: Submit either electronic or
written comments on the draft guidance
by September 11, 2020 to ensure that
the Agency considers your comment on
this draft guidance before it begins work
on the final version of the guidance.
ADDRESSES: You may submit comments
on any guidance at any time as follows:
SUMMARY:
Electronic Submissions
Submit electronic comments in the
following way:
• Federal eRulemaking Portal: https://
www.regulations.gov. Follow the
instructions for submitting comments.
Comments submitted electronically,
including attachments, to https://
www.regulations.gov will be posted to
the docket unchanged. Because your
comment will be made public, you are
E:\FR\FM\13JYN1.SGM
13JYN1
]]>Agencies
[Federal Register Volume 85, Number 134 (Monday, July 13, 2020)]
[Notices]
[Pages 41986-41987]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-15028]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[Docket No. CDC-2020-0077]; [Docket No. NIOSH 338]
Advisory Board on Radiation and Worker Health, National Institute
for Occupational Safety and Health
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting and request for comment.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the
CDC, announces the following meeting of the Advisory Board on Radiation
and Worker Health (ABRWH). This meeting is open to the public, limited
only by the space available. The audio conference line has 150 ports
for callers. The public is welcome to submit written comments in
advance of the meeting, to the contact person below. Written comments
received in advance of the meeting will be included in the official
record of the meeting. The public is also welcome to listen to the
meeting by joining the teleconference (information below).
DATES: The meeting will be held on August 26, 2020 from 1:15 p.m. to
6:15 p.m., EDT and August 27, 2020 from 1:15 p.m. to 6:30 p.m., EDT. An
oral public comment session will be held on August 26, 2020 at 5:15
p.m. and conclude at 6:15 p.m., or following the final call for public
comment, whichever comes first.
Written comments must be received on or before August 21, 2020.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2020-
0077, Docket No. NIOSH-338 by either of the following methods listed
below. CDC does not accept comment by email.
Federal eRulemaking Portal: https://www.regulations.gov.
Follow the instructions for submitting comments.
Mail: Docket No. CDC-2020-0077, Docket number NIOSH-338 c/
o Sherri Diana, NIOSH Docket Office, National Institute for
Occupational Safety and
[[Page 41987]]
Health, 1090 Tusculum Avenue, MS C-34, Cincinnati, Ohio 45226.
Instructions: All submissions received must include the Agency name
and Docket Number. All relevant comments received in conformance with
the https://www.regulations.gov suitability policy will be posted
without change to https://www.regulations.gov, including any personal
information provided. For access to the docket to read background
documents or comments received, go to https://www.regulations.gov.
FOR FURTHER INFORMATION CONTACT: Rashaun Roberts, Ph.D., Designated
Federal Officer, NIOSH, CDC, 1090 Tusculum Avenue, Mailstop C-24,
Cincinnati, Ohio 45226, Telephone (513) 533-6800, Toll Free 1(800)CDC-
INFO, Email [email protected].
SUPPLEMENTARY INFORMATION:
Background: The Advisory Board was established under the
Energy Employees Occupational Illness Compensation Program Act of
2000 to advise the President on a variety of policy and technical
functions required to implement and effectively manage the new
compensation program. Key functions of the Advisory Board include
providing advice on the development of probability of causation
guidelines which have been promulgated by the Department of Health and
Human Services (HHS) as a final rule, advice on methods of dose
reconstruction which have also been promulgated by HHS as a final rule,
advice on the scientific validity and quality of dose estimation and
reconstruction efforts being performed for purposes of the compensation
program, and advice on petitions to add classes of workers to the
Special Exposure Cohort (SEC). In December 2000, the President
delegated responsibility for funding, staffing, and operating the
Advisory Board to HHS, which subsequently delegated this authority to
the CDC. NIOSH implements this responsibility for CDC.
The Advisory Board's charter was issued on August 3, 2001, renewed
at appropriate intervals, rechartered on March 22, 2020, and will
terminate on March 22, 2022.
Purpose: This Advisory Board is charged with (a) providing advice
to the Secretary, HHS, on the development of guidelines under Executive
Order 13179; (b) providing advice to the Secretary, HHS, on the
scientific validity and quality of dose reconstruction efforts
performed for this program; and (c) upon request by the Secretary, HHS,
advising the Secretary on whether there is a class of employees at any
Department of Energy facility who were exposed to radiation but for
whom it is not feasible to estimate their radiation dose, and on
whether there is reasonable likelihood that such radiation doses may
have endangered the health of members of this class.
Matters to Be Considered: The agenda will include discussions on
the following: NIOSH Program Update; Department of Labor Program
Update; Department of Energy Program Update; SEC Petitions Update;
Completed Site Profile Review for W.R Grace Company (Erwin, Tennessee);
Update on Site Profile Review for Idaho National Laboratory Site
(Burial Ground and other Exposure Scenarios), and Hanford (Richland,
Washington); SEC Petition Reviews for Superior Steel (Carnegie,
Pennsylvania; 1952-2957), and Reduction Pilot Plant (Huntington, West
Virginia; 1976-1978), and a Board Work Session. Agenda items are
subject to change as priorities dictate.
Meeting Information: The USA toll-free dial-in number is 1-866-659-
0537; the pass code is 9933701. Web conference by Skype: meeting
Connection: https://webconf.cdc.gov/zab6/yzdq02pl?sl=1.
Public Participation
Comments received are part of the public record and are subject to
public disclosure. Do not include any information in your comment or
supporting materials that you consider confidential or inappropriate
for public disclosure. If you include your name, contact information,
or other information that identifies you in the body of your comments,
that information will be on public display. CDC will review all
submissions and may choose to redact, or withhold, submissions
containing private or proprietary information such as Social Security
numbers, medical information, inappropriate language, or duplicate/near
duplicate examples of a mass-mail campaign. CDC will carefully consider
all comments submitted into the docket. CDC does not accept comment by
email.
Oral Public Comment: An oral public comment session will be held on
August 26, 2020 at 5:15 p.m., EDT and conclude at 6:15 p.m., EDT or
following the final call for public comment, whichever comes first.
Written Public Comment: Written comments will also be accepted from
those unable to attend the public session per the instructions provided
in the address section above. Written comments received in advance of
the meeting will be included in the official record of the meeting.
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2020-15028 Filed 7-10-20; 8:45 am]
BILLING CODE 4163-18-P
